Paul Nouri, CFP
Hedge fund manager, long/short equity, healthcare

If Quest Returns To Its Core Strengths, It Can Deliver Big Returns For Shareholders

Long-term investors are familiar with the chart below and the story that goes with it, but for those that are not familiar, I will go into a brief explanation. From the time Quest Diagnostics (NYSE:DGX) went public in 1996 to 2006, investors were rewarded with a compound annual gain of 33%. These gains were largely the result of a string of acquisitions and the successful integration of said acquisitions. For the past seven years, the stock has been completely flat, logging a performance similar to the S&P 500. So what happened to the extraordinary growth the company's stock price had been experiencing?

(click to enlarge)

The table below illustrates the difference in effect that acquisitions had over the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details